Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL-Reference-Cited by-同舟云学术

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

Published:2004-06 Issue:6 Volume:65 Page:2309-2320
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

de Zeeuw Dick,Remuzzi Giuseppe,Parving Hans-Henrik,Keane William F.,Zhang Zhongxin,Shahinfar Shahnaz,Snapinn Steve,Cooper Mark E.,Mitch William E.,Brenner Barry M.

Publisher

Elsevier BV

Subject

Nephrology

Reference34 articles.

1. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010;Amos;Diabetes Med,1997

2. Global burden of diabetes 1995–2025. Prevalence, numerical estimates and projections;King;Diabetes Care,1998

3. Diabetic nephropathy: Prevention and treatment;Parving;Kidney Int,2001

4. Nephropathy in patients with type 2 diabetes;Remuzzi;N Engl J Med,2002

5. American Diabetes Association: Management of dyslipidemia in adults with diabetes;Diabetes Care,2003

Cited by 828 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling;Metabolism;2024-10

2. Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis;JAMA Oncology;2024-08-01

3. Cardiovascular, renal and mortality risk by the KDIGO heatmap in Japan;Clinical Kidney Journal;2024-07-30

4. Association of remnant cholesterol with renal function and its progression in patients with type 2 diabetes related chronic kidney disease;Frontiers in Endocrinology;2024-07-04

5. Tadalafil versus pentoxifylline in the management of diabetic kidney disease: a randomized clinical trial;Diabetology & Metabolic Syndrome;2024-06-24